Showing 1 to 3 of 3 clinical trials
|
CLINICAL TRIALS Trial No ClinicalTrials.gov ID |
Phase | Coordinator | |
|---|---|---|---|
|
A Phase 1b/3 Study of Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab Alone in Subjects With Previously Untreated Advanced Gastric and Gastroesophageal Junction Cancer With FGFR2b Overexpression
FORTITUDE-102 NCT05111626  Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL L'HOTEL-DIEU DE QUEBEC ET CRCEO |
Maryse Gingras 418-691-5781 |
|
|
Lymph node oesophagus cancer
CT0075 n.d. Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL |
Adeline Jouquan 514-890-8000 poste 26214 |
|
|
A Randomized, Multi-center, Double-blind, Placebo-controlled Phase 3 Study of Bemarituzumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer With FGFR2b Overexpression
FORTITUDE-101 NCT05052801 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Aline Mamo 514-340-8222 poste 5525 |
Groupe d'étude en oncologie du Québec